| Literature DB >> 25884821 |
Olaf von dem Knesebeck1, Horst Bickel2, Angela Fuchs3, Jochen Gensichen4, Susanne Höfels5, Steffi G Riedel-Heller6, Hans-Helmut König7, Karola Mergenthal8, Gerhard Schön9, Karl Wegscheider10, Siegfried Weyerer11, Birgitt Wiese12, Martin Scherer13, Hendrik van den Bussche14, Ingmar Schäfer15.
Abstract
INTRODUCTION: In this article three research questions are addressed: (1) Is there an association between socioeconomic status (SES) and patient-reported outcomes in a cohort of multimorbid patients? (2) Does the association vary according to SES indicator used (income, education, occupational position)? (3) Can the association between SES and patient-reported outcomes (self-rated health, health-related quality of life and functional status) be (partly) explained by burden of disease?Entities:
Mesh:
Year: 2015 PMID: 25884821 PMCID: PMC4322453 DOI: 10.1186/s12939-015-0142-6
Source DB: PubMed Journal: Int J Equity Health ISSN: 1475-9276
Figure 1Sampling procedure.
Sociodemographic and socioeconomic characteristics at baseline (n = 2,729)
| Gender (% females) | 59.1 |
| Age (in years: mean ± sd) | 74.2 ± 5.2 |
| Education (%): | |
| - inadequately completed general education | 1.3 |
| - general elementary education | 13.6 |
| - basic vocational qualification or general elementary education and vocational qualification | 46.0 |
| - intermediate general qualification | 2.5 |
| - intermediate vocational or intermediate general qualification and vocational qualification | 19.9 |
| - general maturity certificate | 1.1 |
| - vocational maturity certificate/general maturity certificate and vocational qualification | 4.0 |
| - lower tertiary education | 4.8 |
| - higher tertiary education | 7.0 |
| Level of autonomy at former occupation (scaled 1–5: mean ± sd) | 2.9 ± 1.2 (n = 2,713) |
| Net household equivalent income (in € per month: mean ± sd) | 1,429 ± 719 (n = 2,424) |
n: number of cases; sd: standard deviation.
Patient-reported outcomes (n = 2,729)
|
|
| |
|---|---|---|
| Self-rated health (scaled 0–100: mean ± sd) | 62.9 ± 18.0 | 63.8 ± 18.8 |
| (n = 2,721) | (n = 2,721) | |
| Functional status (IADL, scaled 0–100: mean ± sd) | 79.2 ± 21.6 | 77.5 ± 22.7 |
| (n = 2,722) | (n = 2,719) | |
| Health related quality of life (EQ-5D, scaled 0–100: mean ± sd) | 80.4 ± 18.9 | 79.9 ± 19.6 |
| (n = 2,723) | (n = 2,723) |
n: number of cases; sd: standard deviation.
GP-reported diseases and severity scores at baseline (n = 2,729 patients)
|
|
| |
|---|---|---|
| Hypertension | 78.0 | 1.7 ± 0.7 |
| Lipid metabolism disorders | 59.2 | 1.3 ± 0.7 |
| Chronic low back pain | 49.7 | 2.0 ± 0.8 |
| Joint arthrosis | 44.1 | 2.0 ± 0.8 |
| Diabetes mellitus | 37.1 | 1.7 ± 0.8 |
| Chronic ischemic heart disease | 31.2 | 1.9 ± 0.8 |
| Thyroid dysfunction | 34.6 | 1.1 ± 0.7 |
| Cardiac arrhythmias | 25.7 | 1.6 ± 0.9 |
| Asthma/COPD | 24.1 | 1.8 ± 0.9 |
| Lower limb varicosis | 23.7 | 1.4 ± 0.8 |
| Osteoporosis | 19.8 | 1.7 ± 0.9 |
| Severe vision reduction | 19.2 | 1.5 ± 0.9 |
| Cancers | 18.1 | 1.4 ± 1.2 |
| Hyperuricemia/Gout | 17.2 | 1.0 ± 0.7 |
| Depression | 16.9 | 1.8 ± 0.7 |
| Atherosclerosis/PAOD | 16.4 | 1.7 ± 0.9 |
| Intestinal diverticulosis | 15.0 | 1.0 ± 0.8 |
| Neuropathies | 14.4 | 1.7 ± 0.8 |
| Chronic gastritis/GERD | 12.9 | 1.5 ± 0.7 |
| Cardiac insufficiency | 12.3 | 1.7 ± 0.8 |
| Cerebral ischemia/Chronic stroke | 11.8 | 1.6 ± 1.0 |
| Prostatic hyperplasia | 11.8 | 1.3 ± 0.7 |
| Renal insufficiency | 10.0 | 1.4 ± 0.8 |
| Cardiac valve disorders | 9.3 | 1.3 ± 0.9 |
| Liver diseases | 7.9 | 0.9 ± 0.8 |
| Dizziness | 7.8 | 1.6 ± 0.7 |
| Hemorrhoids | 7.7 | 1.1 ± 0.8 |
| Chronic cholecystitis/Gallstones | 7.7 | 0.7 ± 0.8 |
| Urinary incontinence | 7.2 | 1.7 ± 0.8 |
| Somatoform disorders | 6.1 | 1.8 ± 0.8 |
| Severe hearing loss | 5.4 | 1.9 ± 0.8 |
| Insomnia | 5.4 | 2.0 ± 0.8 |
| Allergies | 5.0 | 1.4 ± 0.9 |
| Obesity | 4.8 | 2.1 ± 0.9 |
| Anxiety | 4.1 | 1.8 ± 0.7 |
| Rheumatoid arthritis/Chronic polyarthritis | 4.1 | 2.1 ± 0.8 |
| Anemias | 4.0 | 1.2 ± 0.7 |
| Psoriasis | 3.9 | 1.4 ± 0.8 |
| Migraine/chronic headache | 3.6 | 1.4 ± 0.7 |
| Parkinson’s disease | 1.9 | 2.2 ± 0.9 |
| Gynaecological problems | 1.9 | 1.2 ± 0.7 |
| Urinary tract calculi | 1.8 | 1.0 ± 0.8 |
sd: standard deviation.
Association between socioeconomic status (SES) and patient-reported outcomes (self-rated health, functional status and health related quality of life) at : multilevel mixed-effects linear regression
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||||
| Income2 |
|
|
|
|
|
| − |
|
|
|
|
| Education3 |
|
|
|
|
|
| − |
|
|
|
|
| Occupation4 |
|
|
| 0.58 | −0.08-1.25 | 0.089 | −29.3%* | 0.49 | −0.16-1.15 | 0.142 | −40.2%* |
|
| |||||||||||
| Income2 |
|
|
|
|
|
| − |
|
|
| − |
| Education3 | 0.04 | −0.47-0.56 | 0.863 | −0.07 | −0.58-0.43 | 0.781 | −0.13 | −0.63-0.37 | 0.610 | ||
| Occupation4 |
|
|
|
|
|
| − |
|
|
| − |
|
| |||||||||||
| Income2 |
|
|
|
|
|
| − |
|
|
| − |
| Education3 |
|
|
| 0.67 | −0.09-0.72 | 0.084 | −19.3%* | 0.48 | −0.25-1.22 | 0.198 | −42.2%* |
| Occupation4 | 0.44 | −0.29-1.16 | 0.237 | 0.20 | −0.48-0.89 | 0.560 | 0.10 | −0.56-0.76 | 0.772 | ||
Model 1: controlled for age, gender and all other SES indicators; Model 2: Model 1 + diseases; Model 3: Model 1 + disease severity scores.
*Statistically significant (p ≤ 0.05) increase in model fit (Likelihood-ratio test) compared to Model 1.
1Percentage change in coefficient (Model 1 compared separately at a time with Model 2 and Model 3), percentage change is displayed when coefficient is statistically significant in Model 1 (p ≤ 0.05); 2β refers to one step on the logarithmic scale of the variable ranging from 4.2 to 9.1; 3β refers to two steps on the scale of variable ranging from 1 to 9; 4β refers to one step on the scale of variable ranging from 1 to 5.
95% CI: 95% confidence interval; significant associations (p ≤ 0.05) are italicized and bold.
Association between socioeconomic status (SES) and change in patient-reported outcomes (self-rated health, functional status and health related quality of life) - : multilevel mixed-effects linear regression
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||||
| Income2 |
|
|
|
|
|
|
|
|
|
|
|
| Education3 | 0.02 | −0.64-0.70 | 0.944 | 0.06 | −0.60-0.73 | 0.846 | −0.08 | −0.74-0.58 | 0.822 | ||
| Occupation4 | 0.21 | −0.40-0.83 | 0.504 | 0.03 | −0.57-0.64 | 0.911 | 0.05 | −0.55-0.66 | 0.861 | ||
|
| |||||||||||
| Income2 |
|
|
|
|
|
| − |
|
|
|
|
| Education3 | 0.09 | −0.33-0.52 | 0.671 | 0.13 | −0.28-0.55 | 0.535 | 0.06 | −0.35-0.47 | 0.783 | ||
| Occupation4 | 0.11 | −0.58-1.00 | 0.598 | −0.01 | −0.40-0.37 | 0.949 | 0.03 | −0.35-0.41 | 0.884 | ||
|
| |||||||||||
| Income2 |
|
|
|
|
|
|
|
|
|
|
|
| Education3 | 0.13 | −0.55-0.81 | 0.709 | 0.14 | −0.52-0.80 | 0.681 | 0.04 | −0.61-0.69 | 0.899 | ||
| Occupation4 | 0.26 | −0.36-0.88 | 0.408 | 0.05 | −0.55-0.65 | 0.874 | 0.07 | −0.52-0.67 | 0.804 | ||
Model 1: baseline-adjusted and controlled for age, gender and all other SES indicators; Model 2: Model 1 + diseases; Model 3: Model 1 + disease severity scores.
*Statistically significant (p ≤ 0.05) increase in model fit (Likelihood-ratio test) compared to Model 1.
1Percentage change in coefficient (Model 1 compared separately at a time with Model 2 and Model 3), percentage change is displayed when coefficient is statistically significant in Model 1 (p ≤ 0.05); 2β refers to one step on the logarithmic scale of the variable ranging from 4.2 to 9.1; 3β refers to two steps on the scale of variable ranging from 1 to 9; 4β refers to one step on the scale of variable ranging from 1 to 5.
95% CI: 95% confidence interval; significant associations (p ≤ 0.05) are italicized and bold.